With a professional journey spanning over three decades, Jeffrey R. Green has devoted his career to pushing the boundaries of innovation, performance, and leadership within the biotech, pharmaceutical, and medical device industries. Known for his ability to forge strong client relationships, grow revenue in complex markets, and mentor teams to success, Jeffrey’s mission has always remained clear: Bringing Solutions to Biotech and Pharmaceuticals. From hands-on manufacturing leadership to driving multi-million-dollar sales across global markets, his story is one of persistent evolution and deep dedication to life sciences and data-driven excellence.
Jeffrey’s foundational years began with academic training in both Biochemistry and Horticulture at the University of Missouri-Columbia. This dual foundation provided him not only with a solid grasp of life sciences but also a broader appreciation for systemic and organic growth, something that would later mirror his career in enterprise strategy and client development. Additional coursework at UC Berkeley further enhanced his capabilities in chromatography applications and technical writing, reinforcing his ability to communicate complex scientific concepts with precision and clarity.
His early professional years at Cetus Corporation were pivotal. As a Manufacturing Supervisor and later as Manager of Contract Manufacturing, Jeffrey spearheaded the purification and scale-up of biologics such as recombinant beta-interferon and interleukin-2, leading facility buildouts and serving as a liaison during FDA and European inspections. This immersion in GMP compliance, technology transfer, and regulatory rigor laid a powerful groundwork for his later commercial and strategic roles. It was here that his capacity for both detailed operations and high-level coordination truly emerged.
Jeffrey transitioned into commercial roles with Biotage, Dyax, and Tripos, where he honed his talent for technical sales and business development. His work with engineering teams to co-develop novel column technologies and customized separation solutions exemplified his unique blend of scientific understanding and client-focused creativity. Over the years, he expanded these organizations’ customer bases dramatically, often doubling revenue or client engagement metrics in competitive territories. His capacity to scale markets and influence buying decisions was underscored by a deep understanding of his clients’ pain points and aspirations.
His tenure with Evotec, Spotfire (TIBCO), and Oracle marked a period of exponential growth and impact. At Evotec, Jeffrey brought in four new major clients with over $1 million contracts each, opening the Western US to the company’s discovery technologies and ADMET portfolio. At Spotfire, his decade-long leadership in data analytics and visualization resulted in 500% revenue growth, a significant client base expansion, and two consecutive President’s Club recognitions. His success continued at Oracle, where he closed $10+ million in enterprise software sales, driving value for life science and medical device clients through quality and supply chain optimization. While at Oracle, Jeffrey managed up to 20 employees to build and present strategic pitches to prospective clients. He also led the extended sales processes for multiple business units including ERP, HR, Finance, and Engineering—successfully aligning technical teams with enterprise goals.
As his career advanced, Jeffrey remained focused on bringing advanced technology and informatics to the life sciences sector. At Biovia and Lonza, he led collaborations with giants such as Bayer, Celgene, and Shire, enabling the digital transformation of R&D and manufacturing processes across global facilities. His deep involvement in pharmaceutical development cycles and his role in scaling novel therapies positioned him as a strategic partner to some of the industry’s most influential brands.
At PerkinElmer and Aizon, Jeffrey continued to blend technical and commercial fluency with exceptional results. From delivering Spotfire-based clinical data solutions to securing Aizon’s first U.S.-based API manufacturer deal, he consistently introduced technologies that improved process reliability, predictive analytics, and revenue generation for clients. His efforts didn’t just meet quotas—they redefined the standard of engagement and client success across digital health landscapes.
Most recently at 908 Devices, Jeffrey served as the Life Sciences Field Sales Manager, where he was instrumental in opening new markets, particularly within the CDMO segment. His leadership at Genentech’s cell therapy and clinical supply centers exemplifies his enduring commitment to bringing high-impact tools to the forefront of modern medicine. In every engagement, his ability to educate, inspire, and drive adoption of emerging technologies remains unmatched.
Throughout his career, Jeffrey’s international experience in Germany, the UK, and Spain has shaped his global perspective. He brings a unique sensitivity to cross-cultural collaboration, combined with a practical knowledge of regulatory, operational, and sales nuances across borders. His ability to connect with diverse stakeholders—whether in biotech labs, enterprise boardrooms, or international conferences—has fueled his reputation as a leader who listens, builds, and delivers.
Beyond professional achievements, Jeffrey remains active in the broader scientific community. A member of BIO and BioProcessing International, he has contributed to patent development in biotech hardware and spoken publicly at Vancouver conferences on hardware improvements in life sciences. These engagements reflect his commitment to thought leadership and industry advancement.
Character:
Jeffrey’s reputation is grounded in integrity, perseverance, and a deep-rooted desire to help teams and clients thrive. He leads with empathy and accountability, encouraging those around him to aim higher and work collaboratively.
Knowledge:
With decades of domain expertise spanning biochemistry, pharmaceutical sales, informatics, and clinical development, Jeffrey remains a lifelong learner and teacher. His comprehensive understanding of science, business, and technology fuels his ability to simplify complexity and build value-driven strategies.
Strategic:
Jeffrey approaches every challenge with a long-term vision and a structured plan, aligning execution with market trends and business objectives. His record of exceeding growth targets and unlocking new territories showcases his tactical foresight and operational rigor.
Communication:
Known for his clarity, authenticity, and persuasive storytelling, Jeffrey excels at making the technical accessible and the strategic actionable. Whether in one-on-one settings or conference stages, he communicates with purpose and precision.
